Press "Enter" to skip to content

From the Desk of Evan Yu: “Androgen Receptor Mutations in Prostate Cancer; A Worthwhile Therapeutic Target?” – UroToday

admin 0

From the Desk of Evan Yu: “Androgen Receptor Mutations in Prostate Cancer; A Worthwhile Therapeutic Target?”  UroToday

novel AR-inhibiting therapies, therapeutic attempts to target ARv7, galeterone, niclosamide, the importance of the androgen receptor (AR) in prostate cancer, …

“prostate cancer” – Google News

(Visited 2 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *